Pacer Advisors
KROS icon

Pacer Advisors’s Keros Therapeutics KROS Stock Holding History

Pacer Advisors’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-327
Closed -$14.9K – 2629
2024
Q2 		$14.9K Sell
327
-233
-42% -$12.5K ﹤0.01% 3484
2024
Q1 		$37.1K Buy
+560
New +$33.2K ﹤0.01% 3293
2021
Q2 		– Sell
-790
Closed -$49K – 1484
2021
Q1 		$49K Buy
790
+358
+83% +$22.7K ﹤0.01% 1439
2020
Q4 		$30K Buy
+432
New +$27.2K ﹤0.01% 1462

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return